Amundi’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Sell
31,386
-10,141
-24% -$134K ﹤0.01% 1677
2025
Q4
$630K Buy
41,527
+1,086
+3% +$16.6K ﹤0.01% 1395
2025
Q3
$573K Buy
+40,441
New +$531K ﹤0.01% 1289
2024
Q2
Sell
-36,656
Closed -$477K 2012
2024
Q1
$477K Buy
36,656
+34,241
+1,418% +$473K ﹤0.01% 1442
2023
Q4
$35.2K Sell
2,415
-2,098
-46% -$24.6K ﹤0.01% 1918
2023
Q3
$56.1K Hold
4,513
﹤0.01% 1858
2023
Q2
$81.5K Sell
4,513
-76
-2% -$1.42K ﹤0.01% 1811
2023
Q1
$78.8K Buy
+4,589
New +$89.8K ﹤0.01% 1804

Other funds holding OFIX

Amundi's OFIX Position: Q1 2026 in Review

Amundi reduced its Orthofix Medical (OFIX) stake by 24% in Q1 2026, selling an estimated $134K and leaving 31,386 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Amundi first reported a position in OFIX in Q1 2023 and has held it in 8 quarters since. The position peaked at $630K in Q4 2025. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Amundi held 31,386 shares of Orthofix Medical worth $360K as of Q1 2026.
  • Amundi sold 10,141 Orthofix Medical shares in Q1 2026, an estimated $134K.
  • Orthofix Medical made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1677 holding.
  • Amundi first reported a position in Orthofix Medical in Q1 2023 and has held it in 8 quarters since.
  • Amundi's Orthofix Medical position peaked at $630K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.